Bifogade filer
Intellego exceeds 70 MSEK in revenue for Q1-2024
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Intellego Technologies announces a significant financial milestone as its Q1 revenue exceeds 70 million SEK (43) with an expected EBIT above 32 million SEK. This achievement underscores the company's robust sales strategy and the strong market acceptance of its product offerings.
This quarter's remarkable revenue growth can be attributed to a mix of repeat business from loyal customers, the acquisition of new clients, and income generated from Letter of Intent (LOI) projects. Such diverse revenue streams highlight Intellegos' solid market position and the widespread recognition of its value proposition.
While these figures are preliminary, they reflect the company's continuous commitment to excellence and innovation. Intellegos takes pride in its ability to meet and exceed customer expectations, a testament to the efficacy of its sales and marketing efforts and the high quality of its products.
The complete financial report for Q1 will be disclosed on 27th May 2024. It will provide a comprehensive overview of Intellegos' financial performance and strategic direction.